Ann: Immutep Corporate Presentation, page-6

@RLGphd,

I see what your question was. From my experience & knowledge of clinical trials, I am quite confident they would have baselines (but not included as that level of detail for a "corporate" REPORT - not analysis report ).

I obviously do not know the answe as I don't have access to the data at that detail, ...

but the figure on the right on page 17 may "somewhat" help ...

Note after 5 months cd8 counts are (a) the same for two groups, efi and placebo and differentiation is more clear from then on and (b) given normal cd8 level is 150-ish /mm3 (or millions /L) , and should elevate to ip to 1000 IF APC are detected, naturally or assisted, e.g. by efti, then the figure on the right suggests at baseline perhaps the count was the same (as month 5).

Now, I am unsure why 5 months a parent lag ... but PFS figures on page 15 does suggest efti is making a diff from about an early as 2 months.

Note: Figure on the left on page 17 are 13 weeks, 25 week points. 13 weeks is the begining oc C4 (cycle 4).

Hope this helps.